Blood thinners may be unnecessary for minor lung clots, new trial suggests
Disease control
Recruiting now
This study compares two approaches for low-risk patients with small blood clots in the lungs (isolated subsegmental pulmonary embolism). Half will receive standard blood-thinning medication (rivaroxaban), while the other half will get a placebo and be closely monitored. The goal …
Phase: PHASE4 • Sponsor: Drahomir Aujesky • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC